Innovate Biopharmaceuticals Enters into a Collaboration on Larazotide’s Effect on Improving the Microbiome of Children with EED with the University of Virginia School of Medicine
Innovate Biopharmaceuticals (NASDAQ:INNT) has announced a collaboration with James P. Nataro, MD, PHD, MBDA, the Benjamin Armistead Shepherd Professor and Chair, Director of Children’s services, UVA Children’s Hospital of the University of Virginia School of Medicine. As quoted in the press release: Dr. Nataro commented, “I am excited by this collaboration. Abnormalities of intestinal permeability …
Innovate Biopharmaceuticals (NASDAQ:INNT) has announced a collaboration with James P. Nataro, MD, PHD, MBDA, the Benjamin Armistead Shepherd Professor and Chair, Director of Children’s services, UVA Children’s Hospital of the University of Virginia School of Medicine.
As quoted in the press release:
Dr. Nataro commented, “I am excited by this collaboration. Abnormalities of intestinal permeability underlie a host of human diseases such as environmental enteric dysfunction, known as EED. EED is a disorder that afflicts millions of children around the world, leading to growth faltering, cognitive delay and impaired resistance to infection.”
Dr. Nataro has published extensively on intestinal infection and gut health among children in the U.S. and around the world. Dr. Nataro’s lab is funded by the National Institutes of Health (NIH) and independent foundations. His current work on larazotide is funded by the Bill and Melinda Gates Foundation.
Christopher Prior, Ph.D., CEO of Innovate, stated, “Larazotide is the only known molecule in late stage clinical trials that specifically restores intestinal barrier function. We are pleased to be collaborating with Dr. Nataro, and the University of Virginia School of Medicine to research the effects of larazotide on EED. We believe that EED is an unmet need with no current treatment and a serious health concern for millions of children globally.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1765.61 | -3.25 | |
Silver | 19.06 | -0.16 | |
Copper | 3.33 | -0.09 | |
Palladium | 1928.50 | +0.50 | |
Platinum | 857.50 | -7.50 | |
Oil | 99.49 | -0.01 | |
Heating Oil | 3.53 | -0.07 | |
Natural Gas | 5.58 | +0.06 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.